QQQ   277.20 (+2.08%)
AAPL   114.96 (+2.39%)
MSFT   209.44 (+0.78%)
FB   256.82 (+0.78%)
GOOGL   1,458.66 (+1.36%)
AMZN   3,174.05 (+2.55%)
TSLA   421.20 (+3.40%)
NVDA   521.40 (+1.25%)
BABA   276.01 (+1.81%)
CGC   14.21 (+0.28%)
GE   6.20 (+1.47%)
MU   49.72 (+1.18%)
AMD   79.48 (+1.82%)
T   28.38 (+1.21%)
F   6.69 (+2.76%)
ACB   4.78 (-5.35%)
GILD   62.85 (+0.96%)
NFLX   490.65 (+1.61%)
DIS   125.99 (+1.60%)
BA   166.08 (+6.44%)
BAC   24.09 (+2.55%)
QQQ   277.20 (+2.08%)
AAPL   114.96 (+2.39%)
MSFT   209.44 (+0.78%)
FB   256.82 (+0.78%)
GOOGL   1,458.66 (+1.36%)
AMZN   3,174.05 (+2.55%)
TSLA   421.20 (+3.40%)
NVDA   521.40 (+1.25%)
BABA   276.01 (+1.81%)
CGC   14.21 (+0.28%)
GE   6.20 (+1.47%)
MU   49.72 (+1.18%)
AMD   79.48 (+1.82%)
T   28.38 (+1.21%)
F   6.69 (+2.76%)
ACB   4.78 (-5.35%)
GILD   62.85 (+0.96%)
NFLX   490.65 (+1.61%)
DIS   125.99 (+1.60%)
BA   166.08 (+6.44%)
BAC   24.09 (+2.55%)
QQQ   277.20 (+2.08%)
AAPL   114.96 (+2.39%)
MSFT   209.44 (+0.78%)
FB   256.82 (+0.78%)
GOOGL   1,458.66 (+1.36%)
AMZN   3,174.05 (+2.55%)
TSLA   421.20 (+3.40%)
NVDA   521.40 (+1.25%)
BABA   276.01 (+1.81%)
CGC   14.21 (+0.28%)
GE   6.20 (+1.47%)
MU   49.72 (+1.18%)
AMD   79.48 (+1.82%)
T   28.38 (+1.21%)
F   6.69 (+2.76%)
ACB   4.78 (-5.35%)
GILD   62.85 (+0.96%)
NFLX   490.65 (+1.61%)
DIS   125.99 (+1.60%)
BA   166.08 (+6.44%)
BAC   24.09 (+2.55%)
QQQ   277.20 (+2.08%)
AAPL   114.96 (+2.39%)
MSFT   209.44 (+0.78%)
FB   256.82 (+0.78%)
GOOGL   1,458.66 (+1.36%)
AMZN   3,174.05 (+2.55%)
TSLA   421.20 (+3.40%)
NVDA   521.40 (+1.25%)
BABA   276.01 (+1.81%)
CGC   14.21 (+0.28%)
GE   6.20 (+1.47%)
MU   49.72 (+1.18%)
AMD   79.48 (+1.82%)
T   28.38 (+1.21%)
F   6.69 (+2.76%)
ACB   4.78 (-5.35%)
GILD   62.85 (+0.96%)
NFLX   490.65 (+1.61%)
DIS   125.99 (+1.60%)
BA   166.08 (+6.44%)
BAC   24.09 (+2.55%)
Log in
NASDAQ:VIVE

Viveve Medical Stock Forecast, Price & News

$0.53
+0.01 (+1.93 %)
(As of 09/28/2020 12:00 AM ET)
Add
Compare
Today's Range
$0.50
Now: $0.53
$0.53
50-Day Range
$0.51
MA: $0.57
$0.73
52-Week Range
$0.48
Now: $0.53
$9.90
Volume307,178 shs
Average Volume2.96 million shs
Market Capitalization$8.32 million
P/E RatioN/A
Dividend YieldN/A
Beta0.48
Viveve Medical, Inc. designs, develops, manufactures, and markets medical devices for the non-invasive treatment of various post-partum conditions. The company offers Viveve System, a radio frequency generator, a reusable hand piece, and single-use treatment tip, as well as other consumable components. It markets its products through sales employees and distributors in the United States, the Asia Pacific, Europe, the Middle East, Latin America, and Canada. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.
Read More
Viveve Medical logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.85 out of 5 stars


Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:VIVE
Previous SymbolOTCMKTS:PLCSD
CUSIPN/A
Phone720-696-8100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$6.57 million
Book Value$2.34 per share

Profitability

Net Income$-42,530,000.00
Net Margins-828.09%

Miscellaneous

Employees67
Market Cap$8.32 million
Next Earnings Date11/5/2020 (Estimated)
OptionableOptionable
$0.53
+0.01 (+1.93 %)
(As of 09/28/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive VIVE News and Ratings via Email

Sign-up to receive the latest news and ratings for VIVE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Viveve Medical (NASDAQ:VIVE) Frequently Asked Questions

How has Viveve Medical's stock been impacted by COVID-19?

Viveve Medical's stock was trading at $0.84 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, VIVE stock has decreased by 37.0% and is now trading at $0.5290.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Viveve Medical?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Viveve Medical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Viveve Medical
.

When is Viveve Medical's next earnings date?

Viveve Medical is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for Viveve Medical
.

How were Viveve Medical's earnings last quarter?

Viveve Medical Inc (NASDAQ:VIVE) announced its earnings results on Thursday, August, 13th. The company reported ($0.57) EPS for the quarter, beating the consensus estimate of ($0.59) by $0.02. The company earned $0.70 million during the quarter. Viveve Medical had a negative net margin of 828.09% and a negative return on equity of 564.50%.
View Viveve Medical's earnings history
.

Are investors shorting Viveve Medical?

Viveve Medical saw a decrease in short interest in the month of September. As of September 15th, there was short interest totaling 633,700 shares, a decrease of 72.6% from the August 31st total of 2,310,000 shares. Based on an average daily trading volume, of 5,430,000 shares, the days-to-cover ratio is currently 0.1 days. Currently, 4.0% of the company's shares are short sold.
View Viveve Medical's Short Interest
.

Who are some of Viveve Medical's key competitors?

What other stocks do shareholders of Viveve Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Viveve Medical investors own include Corbus Pharmaceuticals (CRBP), Visa (V), HP (HPQ), Fortive (FTV), Lowe's Companies (LOW), SCYNEXIS (SCYX), Western Digital (WDC), Inovio Pharmaceuticals (INO), Viking Therapeutics (VKTX) and Biocept (BIOC).

Who are Viveve Medical's key executives?

Viveve Medical's management team includes the following people:
  • Mr. Scott C. Durbin, CEO & Director (Age 50)
  • Mr. James Gregory Atkinson, Chief Bus. Officer & Pres (Age 61)
  • Mr. Jim B. Robbins, VP of Fin. & Admin., Principal Accounting Officer and Principal Financial Officer (Age 55)
  • Ms. Deborah A. Jorn, Sr. Advisor to the CEO & Director (Age 61)
  • Mr. Martin Kerber, VP of Operations

When did Viveve Medical IPO?

(VIVE) raised $13 million in an IPO on Tuesday, June 14th 2016. The company issued 1,600,000 shares at a price of $8.00 per share. Ladenburg Thalmann and Craig-Hallum Capital Group served as the underwriters for the IPO and Maxim Group was co-manager.

What is Viveve Medical's stock symbol?

Viveve Medical trades on the NASDAQ under the ticker symbol "VIVE."

Who are Viveve Medical's major shareholders?

Viveve Medical's stock is owned by a number of retail and institutional investors. Top institutional investors include Jane Street Group LLC (0.36%).
View institutional ownership trends for Viveve Medical
.

Which major investors are buying Viveve Medical stock?

VIVE stock was acquired by a variety of institutional investors in the last quarter, including Jane Street Group LLC.
View insider buying and selling activity for Viveve Medical
.

How do I buy shares of Viveve Medical?

Shares of VIVE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Viveve Medical's stock price today?

One share of VIVE stock can currently be purchased for approximately $0.53.

How big of a company is Viveve Medical?

Viveve Medical has a market capitalization of $8.32 million and generates $6.57 million in revenue each year. The company earns $-42,530,000.00 in net income (profit) each year or ($33.80) on an earnings per share basis. Viveve Medical employs 67 workers across the globe.

What is Viveve Medical's official website?

The official website for Viveve Medical is www.viveve.com.

How can I contact Viveve Medical?

Viveve Medical's mailing address is 345 INVERNESS DRIVE SOUTH BUILDING B SUITE 250, ENGLEWOOD CO, 80112. The company can be reached via phone at 720-696-8100 or via email at [email protected]

This page was last updated on 9/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.